Core Scientific Announces Fiscal First Quarter 2024 Results Company Announcement - Financial Times
| CORZZ Stock | 14.10 0.29 2.02% |
Slightly above 62% of Core Scientific,'s investor base is looking to short. The current sentiment regarding investing in Core Scientific, Tranche stock implies that many traders are alarmed. Core Scientific,'s investing sentiment can be driven by a variety of factors including economic data, Core Scientific,'s earnings reports, geopolitical events, and overall market trends.
Core |
Core Scientific Announces Fiscal First Quarter 2024 Results Company Announcement Financial Times
Read at news.google.com
 |
Core Scientific, Fundamental Analysis
We analyze Core Scientific,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Core Scientific, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Core Scientific, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Core Scientific, is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Core Scientific, Tranche Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Core Scientific, stock to make a market-neutral strategy. Peer analysis of Core Scientific, could also be used in its relative valuation, which is a method of valuing Core Scientific, by comparing valuation metrics with similar companies.
Peers
Core Scientific, Related Equities
| BB | BlackBerry | 23.83 | ||||
| VERI | Veritone | 5.50 | ||||
| DTSS | Datasea | 4.43 | ||||
| ZS | Zscaler | 2.28 | ||||
| MQ | Marqeta | 1.08 | ||||
| DOCN | DigitalOcean Holdings | 0.71 | ||||
| S | SentinelOne | 0.45 | ||||
| GB | Global Blue | 0.16 | ||||
| JG | Aurora Mobile | 2.81 | ||||
| NN | Nextnav Acquisition | 6.92 |
Additional Tools for Core Stock Analysis
When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.